Medical device makers and members of Congress are growing impatient as CMS sends signals of still further delay on a final decision on a final rule that would automatically provide initial Medicare coverage for new medical products cleared by the FDA as breakthrough devices under Section 510(k). Although it was finalized during the Trump administration,…
MCIT Medicare Coverage Rule Could Be Reimbursement “Breakthrough” for Makers of LDTs
by Glenn S. Demby | May 19, 2021 | Articles, CMS-nir, Compliance-nir, National Lab Reporter, Reimbursement-nir
